Global X China Biotech ETF (02820.HK) Rises 2.65% in Morning Trade, Turnover Reaches HKD 1.6911 Million
NewTimeSpace News: As of August 7 at 10:51, Global X China Biotech ETF (02820.HK) rose 2.65%, with a latest price of HKD 71.920, an opening price of HKD 71.000, a high of HKD 72.060, a low of HKD 71.000, and an intraday amplitude of 1.51%. The ETF traded 23,600 shares, with a turnover of HKD 1.6911 Million and an average price of HKD 71.659. The premium rate is 0.20%, with a turnover rate of 0.26%. The current Net Asset Value (NAV) is HKD 70.162, with Assets Under Management (AUM) of HKD 646 Million, total outstanding shares of 9.20 Million, and a lot size of 50 shares.
Global X China Biotech ETF (02820.HK) tracks the Solactive China Biotech Index NTR (Net Total Return). The constituent stocks of the index are highly concentrated in leading enterprises and boast distinctive innovative characteristics.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares ETFs Daily Report: Biotech Themes Lead as STAR 50 and ChiNext Pull Back - September 17, 2026
- HK shares ETFs Daily Report: Biotech Surges to Lead as Hong Kong New Listings Plunge and Korea/Semiconductor Themes Retreat Sharply — September 14, 2026
- Global X China Biotech ETF (02820.HK) Falls 1.10% in Afternoon Trade, Turnover at HKD 1.2817 Million
- Global X China Biotech ETF (02820.HK) Falls 3.30% in Afternoon Trade, AUM at HKD 695 Million
- HK shares ETFs Daily Report: Biomedicine Rebounds Across the Board! Gold Miners and Leveraged ChiNext Under Pressure and Pull Back - 20260825